IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
about
The effect of SGLT2 inhibitors on cardiovascular events and renal function.Almonds ameliorate glycemic control in Chinese patients with better controlled type 2 diabetes: a randomized, crossover, controlled feeding trial.Current Status of HbA1c BiosensorsTime-dependent effects of ipragliflozin on behaviour and energy homeostasis in normal and type 2 diabetic rats: continuous glucose telemetry analysis.The hundred most-cited publications in microbiota of diabetes research: A bibliometric analysis.Type 2 Diabetes Mellitus and Macrovascular Complications.Baduanjin Exercise for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Safflower Extract and Aceglutamide Injection Promoting Recovery of Peripheral Innervations via Vascular Endothelial Growth Factor-B Signaling in Diabetic Mice.External validation of type 2 diabetes computer simulation models: definitions, approaches, implications and room for improvement-a protocol for a systematic review.FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice.Assessing the Effect of Piperacillin/Tazobactam on Hematological Parameters in Patients Admitted with Moderate or Severe Foot Infections.Ethnicity Does Not Influence Glycemic Outcomes or Diabetes Remission After Sleeve Gastrectomy or Gastric Bypass in a Multiethnic Asian Cohort.Antidiabetic Effects of Artemisia Species: A Systematic Review.Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Health literacy in type 2 diabetes patients: a systematic review of systematic reviews.Ischemic Retinopathies: Oxidative Stress and Inflammation.Diabetic kidney disease in the elderly: prevalence and clinical correlates.Postpartum glucose intolerance: an updated overview.Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.Excessive Autophagy Activation and Increased Apoptosis Are Associated with Palmitic Acid-Induced Cardiomyocyte Insulin Resistance.Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women.Gut hormone polyagonists for the treatment of type 2 diabetes.The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting.Effectiveness and acceptability of continuous glucose monitoring for type 2 Diabetes management: a narrative review.Sheng-ji Hua-yu formula promotes diabetic wound healing of re-epithelization via Activin/Follistatin regulation.Amaranthus caudatus Stimulates Insulin Secretion in Goto-Kakizaki Rats, a Model of Diabetes Mellitus Type 2.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab.Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy.Burden of Proof-When Is Kidney Disease Attributable to Diabetes?A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes.Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care.Mobile Phone Support for Diabetes Self-Care Among Diverse Adults: Protocol for a Three-Arm Randomized Controlled Trial.Female reproductive history and risk of type 2 diabetes: a prospective analysis of 126,721 women.The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies.Glomerular Endothelial Cells Stress and Cross-Talk With Podocytes in the Development of Diabetic Kidney Disease.Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature.The Global Epidemic of the Metabolic Syndrome.
P2860
Q38614488-1B43B0B3-87AD-4D6C-966B-A6BE582CED4AQ41228148-20BF3419-CA6D-4889-8390-189D02A2FCB3Q41584727-B73E3280-7C68-47C5-96E2-048C4A0397B5Q41717553-7CD1CF34-675D-48AD-BAB9-076B8080D0B7Q42360743-C7898F12-E1A3-4513-8D93-8F409F6A8DB8Q45842600-C110B3F9-A5F7-4338-B073-92BC29389D46Q47098038-DD78CB56-7A6A-4CE1-BCE0-BF07A8627B0BQ47112111-CBB51C69-9EF9-4D2C-90C3-D01E3C99F64FQ47116602-2F3F55F8-62C6-4CFA-9DBB-B1296FFC8CDDQ47132703-C94357E7-52D5-45A6-80F5-62921DCF3CF4Q47230552-224CF92F-CD6F-4F4E-BEF8-152853AF7141Q47245568-37C6DB91-52C7-4A9E-86BC-B26B6A8BBEA3Q47263260-08C0CA95-C0D3-457C-A383-8162CF7AD034Q47271368-722A94AE-0620-4BB4-BE57-5E0ED0219F03Q47557757-3427C0FC-A795-4401-899E-3B0AAF33AB4AQ47844670-3694C5FE-7566-480C-B350-2220CF32C2A4Q48095108-880B2FC2-9AB6-4B68-9C5B-ECBD850BE24AQ48113681-183AA4A5-E453-431C-9B50-B5B168B2C8B0Q48238530-4C5CB9AC-2C8E-4591-9A7E-7614928C9F23Q48274275-03A4A6E6-EA33-4B49-BA8F-134A1FEB29ECQ48274920-1654B153-ACC9-4266-BA1A-3067109CDC87Q48366878-C7850950-4491-485C-86C6-67822DD0AD18Q49218095-C6257E5C-9DB9-4AFE-9E21-DFE9CAE20400Q49572596-99E40D3F-9E75-4C73-8AF0-13CAE4F2C12CQ49585801-3492A4AF-B31D-4059-ACC6-1A475B1673DDQ49599865-91EC70B5-A401-4375-9276-980FB7C140C1Q49652125-5EABC4CC-D24A-4698-B106-041A2987EFDCQ49833824-408AD3EF-5C2F-4EEB-B11E-B27D878D9FB1Q49882109-282E27DE-657A-454A-94FF-AC895BE6F920Q50026330-6F376150-A8EF-49BA-AA65-B8FFC78153EFQ50051379-B679570B-F469-4E2A-A4B9-A829A155BC34Q50062786-668DFC88-9134-4B6C-8B0A-7BB3EE5E137CQ51244521-80C89E49-49C2-4BF1-942B-94A887D70FF6Q52321755-F3B74CFB-8414-4C4C-8FB2-BEB49B241F96Q52381615-2160BE31-0B33-495F-8680-65BD09AB5626Q52562168-78FD96D6-2480-4F82-A07D-984E70020563Q52583445-A5952D81-2CE2-43D7-A9E9-7E3266EE46E1Q52599406-4B42249D-E4F8-4891-9CD0-7D36A022D213Q52605864-7AF56931-16AF-4D08-86BA-6EF4A3B2E896Q52685620-5DBC0BD9-5246-453C-9AE4-1C12677C5091
P2860
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
@en
type
label
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
@en
prefLabel
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
@en
P2093
P1476
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
@en
P2093
J D da Rocha Fernandes
K Ogurtsova
L E Makaroff
L Guariguata
U Linnenkamp
P356
10.1016/J.DIABRES.2017.03.024
P577
2017-03-31T00:00:00Z